Evoke Pharma Inc (EVOK) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-12-17

Evoke Pharma Inc (EVOK) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every EVOK SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Evoke Pharma Inc (EVOK)

SEC CIK	0001403708

Recent EVOK Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-12-16	CARLSON MARILYN R.	Chief Medical Officer	J — Other acquisition / disposition	360	—	—	SEC
2025-12-16	GARNER CAM L	Insider	J — Other acquisition / disposition	2.3K	—	—	SEC
2025-12-16	Hill Malcolm R	Insider	J — Other acquisition / disposition	133	—	—	SEC
2025-12-16	Kowieski Mark	Chief Financial Officer	J — Other acquisition / disposition	11.8K	—	—	SEC
2025-12-16	Brady Todd C	Insider	J — Other acquisition / disposition	27	—	—	SEC
2025-12-16	D'Onofrio Matthew J	Chief Executive Officer	J — Other acquisition / disposition	15.5K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Evoke Pharma Inc (EVOK). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2025-12-17 — PYSZCZYMUKA GREG (Insider)
2025-12-17 — Smeal Benjamin C. (Insider)
2025-12-17 — CARLSON MARILYN R. (Chief Medical Officer)
2025-12-17 — GARNER CAM L (Insider)
2025-12-17 — Hill Malcolm R (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EVOK insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

EVOK Insider Trading — FAQ

What is the latest insider trade for EVOK?: Evoke Pharma Inc (EVOK) had 0 insider filings in the last 90 days, with the most recent on 2025-12-17. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying EVOK stock?: 0 insider purchases of EVOK were filed in the last 90 days.
How many insiders are selling EVOK stock?: 0 insider sales of EVOK were filed in the last 90 days.
Where can I see EVOK SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every EVOK SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live EVOK dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.